CDC sole source for proprietary dengue serology reagents.
Some language patterns suggest this RFP may be written for a specific incumbent vendor. Review qualification requirements and brand-specific terms carefully before committing bid resources.
The Centers for Disease Control and Prevention (CDC) intends to award a sole source contract to InBios International, Inc. for the procurement of Serology DV-1-4 EDIII Reagents. These reagents are essential for the CDC's dengue virus serology testing and research. The justification for sole sourcing is based on the proprietary nature of the reagents and the need for compatibility with existing testing protocols. No other vendor can provide the specific reagents required. The contract value is not disclosed but is expected to be under $100,000 based on typical reagent purchases.